Beeld op de omslag

Mexico Pharmaceuticals Report - November 2025

Bewaard in:
Gepubliceerd in:Fitch Solutions Country Industry Reports (Nov 7, 2025), p. 1-56
Gepubliceerd in:
Fitch Solutions Group Limited
Onderwerpen:
Mexico
Pharmaceuticals
Statistical data
Industrywide conditions
Market analysis
Industry analysis
Business forecasts
SWOT analysis
Pharmaceutical industry
Online toegang:Citation/Abstract
Full Text - PDF
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
Samenvatting:Mexico’s pharma sector is poised to expand despite persistent hurdles around procurement and patent protection. Demand for cutting-edge therapies targeting chronic conditions is climbing, and as Latin America’s second-largest market, Mexico offers sizable openings for firms developing innovative medicines. That said, relatively low per-capita drug spending could limit widespread adoption of branded, patented products, likely boosting the role of generics. At the same time, government initiatives to bolster domestic manufacturing are expected to spur more cross-border partnerships, with a particular focus on technology transfer.
ISSN:2976-4750
Bron:ABI/INFORM Trade & Industry